Introduction
GeneFrontier Corporation (GFC) is a Japanese biotech company, which is one of the group companies of KANEKA Corporation. GFC is focusing on biopharmaceutical R&D support business with innovative products and services especially in protein based biologics including antibody.
Also, GFC is looking at next era of antibody therapeutics in Biologics. GFC is developing its own new technology for antibody therapeutics and beyond antibodies, like scaffold.
Our aim is to explore the potential of protein based Biologics, and contributes the development of innovative therapeutics.
Corporate Profile
| Company | GeneFrontier Corporation |
|---|---|
| Established | October 13, 2010 |
| Capital | 10 million yen |
| Board of Directors | CEO Masanobu Sugawara COO Takashi Ebihara Director Mitsuaki Kitano Auditor Takuyuki Kawanishi |
| Shareholders | KANEKA Corporation |
| Access | SHARP Kashiwa Building, 4F 273-1 Kashiwa, Kashiwa-shi, Chiba 277-0005, Japan |
| Phone Facsimile |
TEL：+81-4-7137-6301 FAX：+81-4-7132-7530 |
| contactus01@genefrontier.com |
Partners
Strategic Shareholder